Gender and Advanced Urothelial Cancer: Outcome, Efficacy and Toxicity Following Chemotherapy

Gender and Advanced Urothelial Cancer: Outcome, Efficacy and Toxicity Following Chemotherapy

Background and Objectives: The incidence of urothelial cancer in males is higher than in females; however, females have a higher risk of recurrence and progression. The aim of our study was to report the effect of gender on the oncological outcome in advanced urothelial cancer. Materials and Methods...

Full description

Bibliographic Details
Main Authors: Becattini, L. (Author), Bisegna, C. (Author), Catalano, M. (Author), Conte, F.L (Author), Doni, L. (Author), Galli, I.C (Author), Nesi, G. (Author), Roviello, G. (Author), Saieva, C. (Author), Santi, R. (Author), Serni, S. (Author), Sessa, F. (Author), Spatafora, P. (Author), Villari, D. (Author), Zaccaro, C. (Author)
Format: Article
Language:English
Published: MDPI 2022
Subjects:
gender
muscle-invasive bladder cancer
oncological outcome
toxicity
upper chemotherapy
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items